March 26 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL TO ANNOUNCE EARLY EFFICACY DATA OF LEAD CANDIDATE IN COMBINATION WITH KEYTRUDA® AT AACR ANNUAL MEETING
* BRIACELL THERAPEUTICS - SO FAR, THERE HAS BEEN EXCELLENT SAFETY PROFILE FOR COMBINATION OF BRIA-IMT WITH KEYTRUDA IN ADVANCED BREAST CANCER PATIENTS